medigraphic.com
ISSN 1561-2996 (Electronic)
ISSN 0864-0289 (Print)

2012, Number 3

<< Back Next >>

Rev Cubana Hematol Inmunol Hemoter 2012; 28 (3)

Platelet Functional spectrum: from Hemostasis to Regenerative Medicine

Fernández-Delgado N, Hernández-Ramírez P, Forrellat-Barrios M

Language: Spanish
References: 62
Page: 200-216
PDF size: 161.94 Kb.


ABSTRACT

One of the fundamental basis of regenerative medicine is the therapeutic application of soluble factors involved in biological processes. In recent years, many investigations have shown the involvement of growth factors in the regeneration of different tissues. Platelets can be considered as biological pump or cocktail, due to their content in growth factors which are released by the platelet granules upon activation. For more than two decades, several researchers have reported the benefits of the use of growth factors derived from platelets in the repair and regeneration of different tissues, but in recent years its use has been extended with the employment of different methods for their collection in both, autologous and allogeneic platelets. The procedure for obtaining platelet factor is easy, quick and inexpensive and the results reported in most publications are encouraging, without any reported adverse reactions.


REFERENCES

  1. Lichtman MA, Beutler E, Kipps TJ, Seligsohn V, Kaushansky K, Prchal JT. Platelet morphology biochemistry and function. En: Williams Hematology. 7th ed. New York: McGraw Hill Medical Co.; 2007.

  2. Campbell NA. Biology. 8th ed. London: Pearson Education; 2008. p. 912.

  3. Donné A. De l'origine des globules du sang de leur mode de formation et leur fin. Compt Rend Acad Sci. 1842;14:3668.

  4. Cañizares Proaño C. Las plaquetas. Su morfología, fisiología y patología. Consideraciones sobre las enfermedades hemorrágicas y trombóticas. 2da ed. Quito: Fundacyt; 1997.

  5. Brewer DB. Mark Schultze (1865). G Bizzorero (1882) and the discovery of the platelet. Br J Haematol. 2006;133(3):2518.

  6. Kerstin J, Kehrel BE. Platelets: physiology and biochemistry. Semin Thromb Hemost. 2005;31(4):381-92.

  7. Montón-Echeverría J, Pérez-Redondo S, GómezBajo GJ. Experiencia clínica en el empleo de factores de crecimientos autólogos obtenidos de plasma rico en plaquetas. Cir Plast Iberolatinoam. 2007;33(3):155-61.

  8. Hernández Ramírez P. Medicina regenerativa y células madre. Mecanismos de acción de las células madre. Rev Cubana Hematol Inmunol Hemoter. [serie en Internet]. 2009 Abr; 25(1): Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-02892009000100002&lng=es&nrm=iso&tlng=es

  9. Parazzi V, Lazzari L, Rebulla P. Platelet gel from cord blood: a novel tool for tissue engineering. Platelets. 2010:21(7) 54954.

  10. Wikipedia. Factor de crecimiento (visitada 04-08-2011 y actualizada 20-07-2011) Disponible en: http://es.Wikipedia.org/wiki/Factores_de_crecimiento

  11. Weiser L. Bhargava M, Attia E, Torzilli PA. Effect of serum and platelet-derived growth factor on chondrocytes grown in collagen gels. Tissue Eng. 1999;5:533-44.

  12. Ouyang XY, Qiao J. Effect of platelet-rich plasma in the treatment of periodontal intrabony defects in human. Chin Med J. (Engl) 2006;119(18):1511-21.

  13. Martí -Mestre FX, Acosta-Gómez M, Bonell-Pascual A, Linares-Ruiz P, Romera A, Yñíguez-Navas C, et al. Resultados preliminaries de la aplicación de factores de crecimiento en el tratamiento de las úlceras vasculares. Angiología. 2005;57(4):335-43.

  14. Whitman DH, Berry RL, Green DM. Platelet gel: an autologous alternative to fibrin blue with applcations in oral and maxillofacial surgery. J Oral Maxillofac Surg. 1997:55:1294-8.

  15. Balbo R, Avonto I, Marenchino D, Maddalena L, Menardi G, Peano G. Platelet gel for the treatment of traumatic loss of finger substance. Blood Transfus. 2010;8(4):255-9.

  16. Orozco- Delclós L. Nuevas aplicaciones clínicas del plasma rico en plaquetas en patologías musculoesqueléticas. Conferencia dictada en la Facultad de Medicina de la Universidad Nacional Autónoma de México en el Symposium: Células Madre: del laboratorio a la Clínica. 2006. Disponible en: http://www.google.com.cu/url?sa=t&rct=j&q=Orozco+Delclos+L%2C+2006&source=web&cd=3&ved=0CDEQFjAC&url=http%3A%2F%2Fwww.itrt.es%2Fincludes%2Fdownload.asp%3Ff%3D93%26v%3D0&ei=fLBDT9K_FoTs0gGWxJiCCQ&usg=AFQjCNF7mG7sMmOq4nWpq5IZYg0TGDLWQg

  17. Eppley BL, Pietrzak WS, Blanton M. Platelet-rich plasma: a review of biology and applications in plastic surgery. Plast Reconstr Surg. 2006;118(6):147e-59e.

  18. Knighton DR, Ciresi KF, Fiegel VD, Austin LL, Butler EL. Classification and treatment of chronic nonhealing wounds. Successful treatment with autologous platelet-derived wound healing factors (PDWHF). Ann Surg. 1986 Sep;204(3):322-30.

  19. Carrasco J, Bonete D, Gomar F. Plasma rico en plaquetas vs. Plasma rico en factores de crecimiento. Revista Española de Cirugía Osteoarticular. 2009;239(46):12740.

  20. Rõzman P, Bolta Z. Use of platelet growth factors in treating wounds and softtissue injuries Acta Dermatoven APA. 2007;16(4):156-65.

  21. Romo Rivera J, Gámez Sisaldre LG, Escriva Machado J. Factores de crecimiento en cirugia ortopédica. 2009:5(1): 88-92. Disponible en: http://www.medigraphic.com/pdfs/orthotips/ot -2009/oto91i.pdf

  22. Stellos K, Kopf S, Paul A, Marquardt JU, Gawaz M, Huard J, et al. platelets in regeneration. Semin Thromb Hemost. 2010;36(2):175-84.

  23. Stellos K, Gawaz M. Platelet interaction with progenitor cells: potential implications for regenerative medicine. Thromb Haemost. 2007 Nov;98(5):922-9.

  24. Backly RE, Ulivi V, Tonachini L, Cancedda R, Descalzi F, Mastrogiacomo M. Platelet lysate induces in vitro wound healing of human keratinocytes associated with a strong proinflammatory response. Tissue Eng: Part A. 2011;17(13 y 14):1787-1800.

  25. Mendieta-Archundia TR, AlvaradoSoriano JC, Negrete-Corona J. Utilidad del plasma rico en plaquetas y factores de crecimiento en defectos óseos, experiencia en el Hospital Regional Lic. Adolfo López Mateos del ISSSTE. Acta Ortopédica Mexicana. 2007;15(5):256-60.

  26. Weyrich AS, Zimmerman GA. Platelets: signalling cells inside the immune continuum. Trends Immunol. 2004;25(9):489-95.

  27. Tang YQ, Yeaman MR, Selsted ME. Antimicrobial peptides from human platelets. Infect Immun. 2002;70(12):6524-33 DOI:10.1128/IAI.70.12.6524-6533.2002.

  28. Platelets Concentrates. Transfus Med Hemother. 2009;36(6):372-82. PMID: 21245968

  29. González Lagunas J. Plasma rico en plaquetas. Rev Esp Cir Oral y Maxilofac. 2006;28(2):89-99.

  30. Martínez González JM, Cano Sánchez J, Gonzalo Lafuente JC, Campo Trapero J, Esparza Gómez GC, Seoane Lestón JM. ¿Existen riesgos al utilizar los concentrados de plasma rico en plaquetas (PRP) de uso ambulatorio? Medicina Oral. 2002;7:375-90.

  31. Beca T, Hernández G, Morante S, Bascones A. Plasma rico en plaquetas. Una revision biblografica. Avances en Periodoncia. 2007;19(1):39-52.

  32. Landesberg R, Roy M, Glickman RS. Quantification of growth factor levels using a simplified method of platelet rich plasma gel preparation. J Oral Maxillofac Surg. 2000;58:297-300.

  33. Appel TR, Pötzsch B, Muller J, von Linden JJ, Berge SJ, Reich RH. Comparison of three different preparations of platelet concentrates for growth factor enrichments. Clin Oral Implants Res. 2002;13:522-8.

  34. Weibrich G, Kleis WK. Curasan PRP kit vs PCSS PRP system. Collection efficiency and platelet counts of two different methods for the preparation of platelet rich plasma. Clin Oral Implants Res. 2002;13:437-43.

  35. López-Oliva Muñoz F, Vicario Espinosa R, Almoguera Villacañas JR. Plasma rico en plaquetas. Analisis comparativo de cuatro presentaciones comerciales. Patologia del Aparato Locomotor. 2003;1(1):5966.

  36. Plöderl K, Strasser C, Hennerbichler S, Peterbauer-Scherb A, Gabriel C. Development and validation of a production process of platelet lysate for autologous use. Platelets. 2011;22(3):204-9.

  37. Geremicca W, Fonte C, Vecchio S. Blood components for topical use in tissue regeneration: evaluation of corneal lesions treated with platelet lysate and considerations on repair mechanisms. Blood Transfus. 2010;8:107-12.

  38. Zagai U, Fredriksson K, Rennard SI, Lundahl J, Sköld CM. Platelets stimulate fibroblast-mediated contraction of collagen gels Respir Res. 2003 Oct;4:13.

  39. McAleer JP, Sharma S, Kaplan EM, Persich G. Use of autologous platelet concentrate in a nonhealing lower extremity wound. Advances in Skin & Wound Care. 2006;19(7):354-63. DOI:00129334-200609000-00010.

  40. Greppi N, Mazzucco L, Galetti G, Bona F, Petrillo E, Smacchia C, et al. Treatment of recalcitrant ulcers with allogenic platelet gel from pooled platelets in aged hypomobile patients. Biologicals. 2011;39:73-80.

  41. Perseghin P, Sciurelli G, Beletti D, Speranza T, Pogliani EM, Ferro O, et al. Frozen and thawed allogenic platelets gels for treating postoperative chronic wounds. Transfusion. 2005;45:1544-6.

  42. Zenker S. Le plasma riche en plaquettes(PRP) pour la réjuvénation du visage. J. Med Esth Chir Derm. 2010;XXXVII(148):179-83.

  43. Serra Renom JM, Muñoz del Olmo JL, Gonzalo-Caballero C. Uso de los factores de crecimiento plaquetar unidos a injertos de grasa para lipofiling facial en retidectomia. Cir Plas Iberolatinoam. 2006;36(3):191-8.

  44. Peerbooms JC, van Laar W, Faber F, Schuller HM, van der Hoeven H, Gosens T. Use of platelet rich plasma to treat plantar fasciitis: desing of a multicentre radomized controlled trial. BMC Musculoskeletal Disorders. 2010;11:69. Disponible en: http://www.biomedcentral.com/1471-2474/11/69 doi:10.1186/1471-2474-11-69.

  45. Chiang C, Su C, Huang C, Chen W, Chen T, Tzeng Y. Early experience and results of bone graft enriched with autologous platelet gel for recalcitrant nonunions of lower extremity. J Trauma 2007;63:655-61.

  46. Collazo Álvarez H, Collazo Marin SY, Boada NM. Factores de crecimiento plaquetarios en lesiones traumáticas óseas y pseudotumorales. Rev Cubana Hematol Inmunol Hemoter. 2009;25 (1) Supl. A1. Resúmenes Orales Hematología. Resumen 3-3-21. Disponible en: http://bvs.sld.cu/revistas/hih/vol25-4-09/hih 02409.htm

  47. Thanasas C, Papadimitriou,G, Charalambidis C, Paraskevopoulos I, Papanikolaou A. Platelet-rich plasma versus autologous whole blood for the treatment of chronic lateral elbow epicondylitis. A randomized controlled clinical trial. Am J Sports Med. 2011; Vol. XX, No. X DOI: 10.1177/0363546511417113.

  48. Torabinejad M, Turman M. Revitalization of tooth with necrotic pulp and open apex by using platelet-rich plasma: a case report. JOE. 2011 February;37(2):265-8.

  49. Jiménez- Barragán K, González-Sánchez JG. Uso de plasma rico en factores de crecimiento para disminuir la recurrencia de fístulas nasopalatinas en pacientes con antecedente de paladar hendido. AN ORL MEX. 2011;56(2):63-75.

  50. Yuan NB, Wang C, Wang Y, Yu TT, Shu SQ, Liu M, et al. The preliminary application of autologous platelet-rich gel used to trat refractory diabetic termal ulcer. Sichuan Da Xue Xue Bao Yi Xue Ban. 2007;38(5):900-3.

  51. Artaza H, García S, Hernández P, Fernández N, González AI, González T, et al. Implante de plaquetas en pacientes con insuficiencia arterial crónica de los miembros inferiores, estadio IIb. Rev Cubana Hematol Inmunol Hemoter. [serie en Internet]. 2011;27(4). Resúmenes de la Jornada Científica conjunta del Instituto de Hematología e Inmunología (IHI) y el Hospital General Docente "Enrique Cabrera". Disponible en: http://bvs.sld.cu/revistas/hih/vol27_4_11 /hie11411.htm

  52. García S, Artaza H, Hernández P, Blanco A, Goicoechea P, Atencio E, et al. Implante intralesional de plaquetas en el pie diabético isquémico. Rev Cubana Hematol Inmunol Hemoter. [serie en Internet]. 2011;27(4). Resúmenes de la Jornada Científica conjunta del Instituto de Hematología e Inmunología (IHI) y el Hospital General Docente "Enrique Cabrera". Disponible en: http://bvs.sld.cu/revistas/hih/vol27_4_11/hie11411.htm

  53. Márquez de Aracena R, Montero de Espinosa I, Muñoz M, Pereira G. Aplicación subconjuntival de concentrado de plaquetas plasmáticas en el tratamiento de quemaduras oculares. Resultados preliminares. Arch Soc Esp Oftalmol. 2007;82(8): ISSN 0365-6691 doi:10.4321/S0365-66912007000800005.

  54. Alió JL, Arnalich-Montiel F, Rodriguez AE. The role of "Eye platelet rich plasma" (E-Prp) for wound healing in ophthalmology. Curr Pharm Biotechonol. 2011 Jul 8. (Epub ahead of print.) PMID: 21740369.

  55. Landi A, Tarantino R, Marotta N, Ruggeri AG, Domenicucci M, Gludice L, et al. The use of platelet gel in postero-lateral fusion: preliminary results in a series of 14 cases. Eur Spine J. 2011 may;20(Suppl 1):S61-7.

  56. Khalafi RS, Bradford DW, Wilson MG. Topical application of autologous blood products during surgical closure following a coronary artery bypass grafo. Eur J Cardiothorac Surg. 2008;34(2):360-4.

  57. Doucet C, Ernou I, Zhang Y, Llense JR, Begot L, Holy X, et al. Platelet lysates promote mesenchymal stem cell expansion: a safety substitute for animal serum in cell-based therapy applications. J Cell Physiol. 2005 Nov;205(2):228-36.

  58. Castegnaro S, Chieregato K, Maddalena M, Albiero E, Visco C, Madeo D, et al. Effect of platelet lysate on the functional and molecular characteristics of mesenchymal stem cells isolated from adipose tissue. Curr Stem Cell Res Ther. 2011 Jun 2;6(2):105-14.

  59. Zurita M, Aguayo C, Vaquero J. Utilidad del plasma rico en plaquetas como soporte de células estromales en terapias regenerativas del Sistema Nervioso. Trauma Fund MAPFRE. 2011;22(1):38-46.

  60. Chie Niimura del Barrio M, AtenciaFernández S. Tratamiento con factores de crecimiento plaquetario de una rotura parcial del flexor digital superficial en un caballo de carreras. RCCV. 2007;1(2):208.

  61. Lacci KM, Dardik A. Platelet-rich plasma: support for its use in wound healing. Yale J Biol Med 2010;83:1-9.

  62. Torricelli P, Fini M, Filardo G, Tschon M, Pischedda M, Pacorini A, et al. Regenerative medicine for the treatment of musculoskeletal overuse injuries in competition horses. Int Orthop. 2011;35(10):1569-76.




2020     |     www.medigraphic.com